AU6904896A - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
AU6904896A
AU6904896A AU69048/96A AU6904896A AU6904896A AU 6904896 A AU6904896 A AU 6904896A AU 69048/96 A AU69048/96 A AU 69048/96A AU 6904896 A AU6904896 A AU 6904896A AU 6904896 A AU6904896 A AU 6904896A
Authority
AU
Australia
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69048/96A
Inventor
Richard E Moore
Vinod F. Patel
James E. Ray
John E. Toth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Hawaii
Wayne State University
Eli Lilly and Co
Original Assignee
University of Hawaii
Wayne State University
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Hawaii, Wayne State University, Eli Lilly and Co filed Critical University of Hawaii
Publication of AU6904896A publication Critical patent/AU6904896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
AU69048/96A 1995-08-30 1996-08-30 Pharmaceutical compounds Abandoned AU6904896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US293595P 1995-08-30 1995-08-30
US002935 1995-08-30
PCT/US1996/013855 WO1997007798A1 (en) 1995-08-30 1996-08-30 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
AU6904896A true AU6904896A (en) 1997-03-19

Family

ID=21703268

Family Applications (2)

Application Number Title Priority Date Filing Date
AU69048/96A Abandoned AU6904896A (en) 1995-08-30 1996-08-30 Pharmaceutical compounds
AU71090/96A Ceased AU709828B2 (en) 1995-08-30 1996-08-30 Cryptophycins from aberrant biosynthesis

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU71090/96A Ceased AU709828B2 (en) 1995-08-30 1996-08-30 Cryptophycins from aberrant biosynthesis

Country Status (6)

Country Link
EP (2) EP0850316A4 (en)
JP (2) JP2000501067A (en)
AU (2) AU6904896A (en)
BR (1) BR9610214A (en)
CA (2) CA2246117A1 (en)
WO (2) WO1997008334A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000501067A (en) * 1995-08-30 2000-02-02 イーライ・リリー・アンド・カンパニー Pharmaceutical compounds
EP0869786B1 (en) * 1995-12-22 2003-03-05 Eli Lilly And Company Pharmaceutical compounds
US6680311B1 (en) 1996-08-30 2004-01-20 Eli Lilly And Company Cryptophycin compounds
US5977387A (en) * 1996-08-30 1999-11-02 Eli Lilly And Company Process for preparing pharmaceutical compounds
DE69736067T9 (en) * 1996-08-30 2007-10-31 University Of Hawaii, Honolulu NEW CRYPTOPHYCIN DERIVATIVES AS ANTINEOPLASTICS
WO1998008506A1 (en) * 1996-08-30 1998-03-05 Eli Lilly And Company Pharmaceutical compounds
US6020512A (en) * 1996-09-06 2000-02-01 Eli Lilly And Company Process and novel intermediates
CA2264527A1 (en) * 1996-09-06 1998-03-12 Eric David Moher Process to prepare pharmaceutical compounds
EA199900770A1 (en) * 1997-02-26 2000-04-24 Эли Лилли Энд Компани METHOD OF OBTAINING PHARMACEUTICAL COMPOUNDS
AU6338698A (en) * 1997-02-26 1998-09-18 Eli Lilly And Company Tripeptide and tetrapeptide pharmaceutical compounds
EP0870501A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections
EP0870506A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer
US6180679B1 (en) * 1998-04-07 2001-01-30 Eli Lilly And Company Method for treating fungal infections
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
US6376230B1 (en) 1998-10-16 2002-04-23 Eli Lilly And Company Stereoselective process for producing intermediates of cryptophycins
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
WO2003077906A1 (en) * 2002-03-18 2003-09-25 Nihon University Cyclic etheramine derivatives as medicaments for malignant tumors
WO2005116200A2 (en) 2004-05-05 2005-12-08 Regents Of The University Of Minnesota Nucleic acids and polypeptides involved in the production of cryptophycin
US20110098477A1 (en) * 2005-06-28 2011-04-28 Chugai Seiyaku Kabushiki Kaisha Method Of Producing Compound Having Anti-Hcv Activity
CN103724290B (en) * 2013-11-15 2015-04-29 浙江大学 Cyclopeptide compound clavatustide A as well as producing strain, preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868208A (en) * 1988-07-15 1989-09-19 Merck & Co., Inc. Antifungal agent and method
US4946835A (en) * 1988-07-15 1990-08-07 Merck & Co., Inc. Antifungal fermentation product and method
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US5952298A (en) * 1993-12-21 1999-09-14 The University Of Hawaii Cryptophycins
TJ347B (en) * 1995-03-07 2002-10-06 Univ Hawaii Cryptophicin compounds pharmacentical composition method to inhibit the proliteration of cells and and method to treat neoplasia
JP2000501067A (en) * 1995-08-30 2000-02-02 イーライ・リリー・アンド・カンパニー Pharmaceutical compounds

Also Published As

Publication number Publication date
WO1997008334A1 (en) 1997-03-06
JP2000507805A (en) 2000-06-27
EP0850057A4 (en) 2001-04-11
EP0850316A4 (en) 2000-08-23
EP0850316A1 (en) 1998-07-01
CA2230540A1 (en) 1997-03-06
JP2000501067A (en) 2000-02-02
AU709828B2 (en) 1999-09-09
AU7109096A (en) 1997-03-19
EP0850057A1 (en) 1998-07-01
CA2246117A1 (en) 1997-03-06
WO1997007798A1 (en) 1997-03-06
BR9610214A (en) 1999-06-15

Similar Documents

Publication Publication Date Title
AU6216296A (en) Pharmaceutical compositions
AU6995396A (en) Pharmaceutical formulation
AU7572196A (en) Pharmaceutical formulations
AUPN411195A0 (en) Medicinal composition
AU2533495A (en) Pharmaceutical diketopiperazine compounds
AU6973396A (en) Pharmaceutical formulation
AU7590096A (en) Drug composition
AU6904896A (en) Pharmaceutical compounds
AU8591898A (en) Pharmaceutical compounds
AU5155096A (en) Pharmaceutical composition
AU4330097A (en) Pharmaceutical compounds
AU5274096A (en) Pharmaceutical compositions
AU3542993A (en) Pharmaceutical compounds
AU4839196A (en) Polyazacycloalkane compounds
AU7582696A (en) Pharmaceutical formulation
AU5280396A (en) Pharmaceutical microencapsulation
AU4169897A (en) Pharmaceutical compounds
AU1217797A (en) New compounds
AU1475595A (en) Pharmaceutical preparation
AU7546096A (en) Pharmaceutical compounds
AU6657596A (en) Trindene compounds
AU6814496A (en) Pharmaceutical composition
AU723097C (en) Pharmaceutical composition
AU741226C (en) Pharmaceutical composition
AU6607094A (en) Pharmaceutical compounds